VEGFA and gastric cancer: It was observed that the metastatic potential of GC could be potentially inhibited by the usage of interleukin-1 receptor antagonist (IL-1RA), which at the same time inhibits the IL-1α/VEGF signalling pathway lowering VEGF expression and further tube formation [142].